[1] World Health Organization. Virtual press conference on COVID-19 - 11 March 2020. 2020. https://www.who.int/docs/default-source/coronaviruse/transcripts/who-audio-emergencies-coronavirus-press-conference-full-and-final-11mar2020.pdf?sfvrsn=cb432bb3_2. [2020-03-11].https://www.who.int/docs/default-source/coronaviruse/transcripts/who-audio-emergencies-coronavirus-press-conference-full-and-final-11mar2020.pdf?sfvrsn=cb432bb3_2
[2] World Health Organization. Novel coronavirus (COVID-19) situation. 2020. https://experience.arcgis.com/experience/685d0ace521648f8a5beeeee1b9125cd. [2020-03-20].https://experience.arcgis.com/experience/685d0ace521648f8a5beeeee1b9125cd
[3] Mahase E. Coronavirus: covid-19 has killed more people than SARS and MERS combined, despite lower case fatality rate. BMJ 2020;368:m641. http://dx.doi.org/10.1136/bmj.m641CrossRef
[4] Sands P, EI Turabi A, Saynisch PA, Dzau VJ. Assessment of economic vulnerability to infectious disease crises. Lancet 2016;388(10058):2443 − 8. http://dx.doi.org/10.1016/S0140-6736(16)30594-3CrossRef
[5] National Health and Family Planning Commission. 2014 report on Chinese resident’s chronic disease and nutrition. People’s Medical Publishing House. 2015. http://www.chinadaily.com.cn/m/chinahealth/2015-06/15/content_21008408_2.htm.http://www.chinadaily.com.cn/m/chinahealth/2015-06/15/content_21008408_2.htm
[6] Zhu N, Zhang DY, Wang WL, Li XW, Yang B, Song JD, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020;382(8):727 − 33. http://dx.doi.org/10.1056/NEJMoa2001017CrossRef
[7] Wu ZY, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the chinese center for disease control and prevention. JAMA 2020. http://dx.doi.org/10.1001/jama.2020.2648CrossRef
[8] Huang CL, Wang YM, Li XW, Ren LL, Zhao JP, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395(10223):497 − 506. http://dx.doi.org/10.1016/S0140-6736(20)30183-5CrossRef
[9] Weston D, Hauck K, Amlôt R. Infection prevention behaviour and infectious disease modelling: a review of the literature and recommendations for the future. BMC Public Health 2018;18(1):336. http://dx.doi.org/10.1186/s12889-018-5223-1CrossRef
[10] Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol 2020. http://dx.doi.org/10.1038/s41569-020-0360-5CrossRef
[11] Ji YP, Ma ZR, Peppelenbosch MP, Pan QW. Potential association between COVID-19 mortality and health-care resource availability. Lancet Glob Health 2020;8(4):PE480. http://dx.doi.org/10.1016/S2214-109X(20)30068-1CrossRef